Persistent Atrial Fibrillation
199
30
48
72
Key Insights
Highlights
Success Rate
86% trial completion
Published Results
37 trials with published results (19%)
Research Maturity
72 completed trials (36% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
6.0%
12 terminated out of 199 trials
85.7%
-0.8% vs benchmark
6%
12 trials in Phase 3/4
51%
37 of 72 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 72 completed trials
Clinical Trials (199)
VOLT-AF IDE Clinical Study
Correlation of the Arrhythmia Mechanism and Substrate to Ablate Persistent Atrial Fibrillation Study
VOLT CE Mark Study
Acute Responses to Exercise in Females and Males With Symptomatic Atrial Fibrillation
Evaluation of Novel Waveforms Delivered Using the FARAPULSE™ PFA System
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
Feasibility Study of the FARAFLEX Mapping and PFA System
PVI Alone vs PVI and Linear Ablation for Persistent Atrial Fibrillation (PROMPT AF II)
REPRESENT-PF Registry
Pragmatic Evaluation of a Pentaspline Pulsed Field Ablation System to Treat Atrial Fibrillation and Related Arrhythmias
iCLAS™ Cryoablation System Post-Market Clinical Follow-up (PMCF) Study
Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
iCLAS™ for Persistent Atrial Fibrillation
BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF
PREACTIVE: Preconditioning Exercise Intervention to Improve Symptoms and Quality of Life in Comorbid Atrial Fibrillation and HFpEF
Study on the Prevention of Atrial Fibrillation Recurrence After Ablation by Qidong Yixin Granule
SPHERE Per-AF Post-Approval Study
Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation
Left Atrial Arrhythmia Substrate Identification After Confirmed durABLE Pulmonary Vein Isolation
The PIFPAF-PFA Study